AAM
REGN icon

Alphadyne Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Alphadyne Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.56M Buy
5,900
+2,200
+59% +$1.68M 0.08% 311
2025
Q4 		$2.86M Buy
3,700
+2,100
+131% +$1.43M 0.07% 268
2025
Q3 		$900K Buy
+1,600
New +$905K 0.07% 199

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Alphadyne Asset Management's REGN Position: Q1 2026 in Review

Alphadyne Asset Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q1 2026: 754 shares worth $583K. The stake represents 0.01% of the portfolio and ranks #666 among its holdings. This is a return to the name: Alphadyne Asset Management previously reported a position in REGN as recently as Q3 2025.

Alphadyne Asset Management first reported a position in REGN in Q3 2023 and has held it in 3 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Alphadyne Asset Management held 754 shares of Regeneron Pharmaceuticals worth $583K as of Q1 2026.
  • Regeneron Pharmaceuticals was a new Alphadyne Asset Management position in Q1 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Alphadyne Asset Management's portfolio in Q1 2026, its #666 holding.
  • Alphadyne Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2023 and has held it in 3 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Alphadyne Asset Management's 13F filing for Q1 2026, filed 15 May 2026.